Amélie is currently completing her Bachelor’s in Nanobiology at the Technical University of Delft.
At IDEVAX, she will work in the Scientific and Clinical Affairs department, focusing on the potential of the VAX-ID device in clinical trials and drug delivery, particularly for SARS-COV-2 vaccines. Her goal is to understand the operations of a medical device company while enhancing my scientific writing and research interpretation skills.
